image credit: Gage Skidmore / Flickr

Trump signs deal with company in effort shift drug manufacturing to U.S.: New York Times

May 19, 2020

Via: Reuters

(Reuters) – The United States will announce on Tuesday that it has signed a $354 million contract with a company to make generic medicines and pharmaceutical ingredients in the country needed to treat COVID-19, the New York Times reported late on Monday.

The move is part of efforts to bring pharmaceutical manufacturing to the United States from abroad. Phlow Corp is a generic drug maker based in Virginia which makes medicines overseas, mostly in India and China.

Read More on Reuters